ReviewHealthcare (Basel, Switzerland)2025
Taiwan's Smart Healthcare Value Chain: AI Innovation from R&D to Industry Deployment.
Review in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Community-based health-focused longitudinal aging studies in East and Southeast Asia: landscape and future directions.The Lancet regional health. Western Pacific · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Taiwan's strategic focus in digital healthcare has been officially integrated into national industrial policy and identified as a crucial application area for artificial intelligence (AI) and next-generation communication technologies. As the healthcare sector undergoes rapid digital transformation, digital healthcare technologies have emerged as essential tools for improving medical quality and efficiency. Leveraging the extensive coverage of its National Health Insurance (NHI) system and its strengths in Information and Communications Technology (ICT), Taiwan also benefits from the robust research capacity of universities and hospitals. Government-driven regulatory reforms and infrastructure initiatives are further accelerating the advancement of the NHI MediCloud system and the broader digital healthcare ecosystem. This article provides a comprehensive overview of smart healthcare development, highlighting government policy support and the R&D capabilities of universities, research institutes, and hospitals. It also examines the ICT industry's participation in the development of smart healthcare ecosystems, such as Foxconn, Quanta, Acer, ASUS, Wistron, Qisda, etc. With strong data assets, technological expertise, and policy backing, Taiwan demonstrates significant potential in both AI innovation and smart healthcare applications, steadily positioning itself as a key player in the global healthcare market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.